SCHEDULE: Squadron Funds Report Spruce Biosciences Stake

Squadron Master Fund LP, Squadron Capital Management LLC, Matthew Sesterhenn, and William Blank have reported beneficial ownership of 12,200 shares, representing 0.9% of Spruce Biosciences, Inc. common stock.

Summary

• Squadron Master Fund LP, along with its investment advisor Squadron Capital Management, LLC, and individuals Matthew Sesterhenn and William Blank, have filed a Schedule 13G.
• The filing indicates beneficial ownership of 12,200 shares of Spruce Biosciences, Inc. common stock.
• This ownership represents 0.9% of the total outstanding shares.
• The reporting entities are Squadron Master Fund LP (a Delaware limited partnership), Squadron Capital Management, LLC (a Delaware limited liability company registered as an Exempt Reporting Adviser), Matthew Sesterhenn (US citizen), and William Blank (US citizen).
• Squadron Capital Management, LLC serves as the investment adviser to Squadron Master Fund LP and may be deemed beneficial owner of the shares held by the fund.
• Matthew Sesterhenn and William Blank, as Partners of Squadron Capital Management, LLC, may also be deemed beneficial owners due to their investment and voting discretion.
• However, Squadron Capital Management, LLC, Mr. Sesterhenn, and Mr. Blank expressly disclaim beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership without significant new information or strategic changes.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the company.

Management Comments

• Squadron Capital Management, LLC, which serves as investment adviser to private funds, including but not limited to Squadron Master Fund LP (collectively, the "Funds"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Funds.
• Mr. Sesterhenn and Mr. Blank, as Partners of Squadron Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all shares of Common Stock held by the Funds.
• Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, Squadron Capital Management, LLC and Mr. Sesterhenn and Mr. Blank expressly disclaim beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that Squadron Capital Management, LLC or Mr. Sesterhenn and Mr. Blank are the beneficial owner of any of the securities reported herein.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors and investment managers exceeding a certain ownership threshold, indicating passive investment intent rather than control.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant beneficial ownership, which is standard for market participants.
• Management: The filing confirms the ownership stake of Squadron Funds and its associated individuals, which is a routine disclosure.

Key Dates

Keywords

Schedule 13G, Spruce Biosciences, Squadron Master Fund LP, Squadron Capital Management LLC, Beneficial Ownership, SEC Filing, Common Stock, Investment Adviser